Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$6.01
-0.350 (-5.50%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Nov 12, 2021 $49.47 $49.51 $47.35 $48.27 258 950
Nov 11, 2021 $49.93 $50.96 $47.32 $48.57 179 930
Nov 10, 2021 $49.88 $52.36 $48.39 $49.30 313 564
Nov 09, 2021 $52.01 $53.70 $48.91 $49.90 178 202
Nov 08, 2021 $55.08 $55.72 $50.50 $52.02 255 429
Nov 05, 2021 $54.46 $56.18 $53.13 $53.78 254 766
Nov 04, 2021 $54.90 $55.54 $53.09 $54.49 166 366
Nov 03, 2021 $53.15 $54.94 $51.40 $54.82 258 131
Nov 02, 2021 $50.13 $53.56 $48.58 $52.94 196 090
Nov 01, 2021 $46.16 $50.10 $46.04 $49.67 238 130
Oct 29, 2021 $48.21 $48.45 $45.94 $46.39 324 599
Oct 28, 2021 $45.86 $48.39 $45.01 $48.07 261 141
Oct 27, 2021 $45.42 $46.33 $43.84 $45.53 121 873
Oct 26, 2021 $44.81 $46.14 $44.60 $45.80 172 952
Oct 25, 2021 $43.08 $44.52 $41.52 $44.51 166 183
Oct 22, 2021 $43.82 $43.82 $41.36 $42.72 175 641
Oct 21, 2021 $44.66 $45.99 $43.75 $43.97 198 328
Oct 20, 2021 $45.80 $46.22 $44.12 $44.81 204 875
Oct 19, 2021 $43.31 $46.47 $43.31 $45.96 209 049
Oct 18, 2021 $43.72 $44.51 $42.53 $43.39 178 702
Oct 15, 2021 $46.01 $46.33 $43.19 $43.93 151 793
Oct 14, 2021 $43.53 $46.88 $42.02 $45.33 306 000
Oct 13, 2021 $44.48 $44.96 $41.66 $43.05 353 858
Oct 12, 2021 $45.22 $45.78 $43.33 $44.20 329 067
Oct 11, 2021 $43.94 $45.02 $43.24 $44.76 231 769
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT